With a focus on new variants and global surges in COVID-19 cases, the world remains on guard to respond to new guidance and potential lockdowns.
Ongoing epidemiological updates on new cases in the unvaccinated, breakthrough infections in the vaccinated, and re-infections in recovered patients have been important guideposts for action.
The diagnosis of COVID-19 includes two approaches - identifying those infected with COVID-19 and identifying those who are infectious with competent virus.
Join this webinar to hear global experts discuss the benefits, latest studies, and rationale for large-scale use of antigen testing as an essential and effective tool in our global testing arsenal.
Michael Mina, MD, PhD — USA
Topic: Re-calibration in the use of Ag test in the fight against the COVID-19 epidemic.
Mary Rodgers, PhD — USA
Topic: The Abbott Global Surveillance Program- SARS-CoV-2 variant vigilance.
Amilcar Tanuri, MD, PhD — Brazil
Topic: High correlation of Virological confirmation on subject infected with COVID-19 when the Ag test is positive.
Luis Gonzalez, MD, PhD
Global Director of Medical and Scientific Affairs - Abbott
Norman Moore, PhD
Global Director of Scientific Affairs, Infectious Diseases - Abbott
Based on your current location, the content on this page may not be relevant for your country.